Financial & Business News

Three U.S. chip stocks have 25% or more of their floated shares sold short, indicating a very high level of bearish sentiment among a certain group of investors.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-form?prid=140962&wire=1 or contact Joseph E. Levi, Esq.

There's a lot of uncertainty in the stock market right now, and it's causing many investors to reconsider some of their stocks and look at which ones might offer good opportunities to buy. With U.S. President Donald Trump's ongoing tariff actions against trade partners and some economists increasing their estimates of a potential recession, it's no surprise that investors are taking a more skeptical approach to each stock they buy.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Fluence Energy, Inc. (NASDAQ:FLNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluence-energy-lawsuit-submission-form?prid=140961&wire=1 or contact Joseph E. Levi, Esq.

PHILADELPHIA , April 4, 2025 /PRNewswire/ --  Berger Montague PC advises investors that a securities class action lawsuit has been filed against Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) on behalf of purchasers of Rocket Lab securities between November 12, 2024 through February 25, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired ROCKET LAB securities during the Class Period may, no later than APRIL 28, 2025 , seek to be appointed as a lead plaintiff representative of the class.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, shared the following update related to ELEVIDYS (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with Duchenne muscular dystrophy. Following the safety update on acute liver failure that was issued on March 18, European Union (EU) reference member country authorities requested that the independent data monitoring committee (DMC).

Fears that President Trump's tariffs could slash global economic growth — and demand for oil as a result — were weighing on the market.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

In contrast with the S&P 500 index's worst quarterly performance since the bear market of early 2022, share prices of streaming television service FuboTV (FUBO -4.44%) rose 132% in Q1. This strength turns heads, particularly when the overall market struggles.

SARA Receives Overall Judges' Choice Honors Plus Best in Threat Detection and Response Solutions at ISC West Detroit, Michigan--(Newsfile Corp. - April 4, 2025) - Artificial Intelligence Technology Solutions, Inc., (OTC Pink: AITX), today announced that its wholly owned subsidiary Robotic Assistance Devices, Inc., (RAD), has received two major awards at the 2025 Security Industry Association (SIA) New Products and Solutions (NPS) Awards. SARA™, RAD's AI-powered incident response platform, earned the prestigious Judges' Choice Award and was also selected as the winner in the Threat Detection and Response Solutions category.